NFKB1 and acute myeloid leukemia: The role of NF-κB in leukemogenesis is evident from the studies where blocking the expression of NF-κB using an inhibitor molecule BMS-345541 altered the expression of genes central to leukemogenesis in patient-derived AML cells (51).